C7515

Sigma-Aldrich

Cannabidiol

Empirical Formula (Hill Notation):
C21H30O2
CAS Number:
Molecular Weight:
314.46
MDL number:

drug control

USDEA Schedule I; regulated under CDSA - not available from Sigma-Aldrich Canada

storage temp.

2-8°C

InChI

1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18?/m0/s1

InChI key

QHMBSVQNZZTUGM-ZENAZSQFSA-N

Looking for similar products? Visit Product Comparison Guide

Biochem/physiol Actions

Not psychoactive in humans.

Other Notes

Major component of marijuana from C. sativa

Pictograms

Exclamation markHealth hazard

Signal Word

Warning

Hazard Statements

hazcat

Acute Tox. 4 Oral - Repr. 2

storage_class_code

11 - Combustible Solids

WGK Germany

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves

Certificate of Analysis

Certificate of Origin

Stephen D Skaper et al.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 367(1607), 3193-3200 (2012-10-31)
The psychoactive component of the cannabis resin and flowers, delta9-tetrahydrocannabinol (THC), was first isolated in 1964, and at least 70 other structurally related 'phytocannabinoid' compounds have since been identified. The serendipitous identification of a G-protein-coupled cannabinoid receptor at which THC...
Amir Englund et al.
Journal of psychopharmacology (Oxford, England), 27(1), 19-27 (2012-10-09)
Community-based studies suggest that cannabis products that are high in Δ⁹-tetrahydrocannabinol (THC) but low in cannabidiol (CBD) are particularly hazardous for mental health. Laboratory-based studies are ideal for clarifying this issue because THC and CBD can be administered in pure...
Marcos Hortes N Chagas et al.
Journal of psychopharmacology (Oxford, England), 27(3), 312-316 (2013-01-25)
Cannabidiol (CBD) is one of the main components of Cannabis sativa and has a wide spectrum of action, including effects in the sleep-wake cycle. The objective of this paper is to assess the effects on sleep of acute systemic administration...
Serena Deiana
Drug testing and analysis, 5(1), 46-51 (2012-10-31)
The medical properties of cannabis have been known for many centuries; its first documented use dates back to 2800 BC when it was described for its hallucinogenic and pain-relieving properties. In the first half of the twentieth century, a number...
Celia Oreja-Guevara
Revista de neurologia, 55(7), 421-430 (2012-09-27)
Spasticity remains a prevalent symptom in multiple sclerosis, with a significant associated disability and quality of life impairment. A significant improvement in therapy aimed at reducing multiple sclerosis relapses and modifying its course has been achieved in recent years. Both...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service